£2.9M
The funding round will support the clinical development of the company's transdermal testosterone patch for post-menopausal women.
"Having the funding in place for the first clinical trial of our testosterone patch for post-menopausal women will enable Medherant to take a major step towards registration of the product and being able to address this significant gap in the options available for women in this very important stage of their lives."
